Seminars in Nuclear Medicine
Volume 34, Issue 4 , Pages 313-329 , October 2004

Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders

  • Ghassan El-Haddad

      Affiliations

    • Division of Nuclear Medicine, Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
    • ,
  • Hongming Zhuang

      Affiliations

    • Division of Nuclear Medicine, Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
    • ,
  • Naresh Gupta

      Affiliations

    • Academic Radiology, Baltimore, MD, USA.
    • ,
  • Abass Alavi

      Affiliations

    • Division of Nuclear Medicine, Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
    • Corresponding Author InformationAddress reprint requests to: Abass Alavi, MD, Division of Nuclear Medicine, Hospital of the University of Pennsylvania, 110 Donner Bldg, 3400 Spruce Street, Philadelphia, PA 19104.

References 

  1. Warburg O . In: The Metabolism of Tumors . London: Arnold Constable; 1930;p. 75–327
  2. Avril N , Menzel M , Dose J , et al.   Glucose metabolism of breast cancer assessed by F-18-FDG PET (Histologic and immunohistochemical tissue analysis) . J Nucl Med . 2001;42:9–16
  3. Ak I , Stokkel MPM , Pauwels EKJ . Positron emission tomography with 2-[F-18]fluoro-2-deoxy-D-glucose in oncology Part II (The clinical value in detecting and staging primary tumours) . J Cancer Res Clin Oncol . 2000;126:560–574
  4. Bakheet SM , Powe J . Benign causes of 18-FDG uptake on whole body imaging . Semin Nucl Med . 1998;28:352–358
  5. Lehmann K , Behe M , Meller J , et al.   F-18-FDG uptake in granulocytesBasis of F-18-FDG scintigraphy for imaging infection [abstract] (Basis of F-18-FDG scintigraphy for imaging infection [abstract]) . J Nucl Med . 2001;42:1384
  6. Chakrabarti R , Jung CY , Lee TP , et al.   Changes in glucose-transport and transporter isoforms during the activation of human peripheral blood lymphocytes by phytohemagglutinin . J Immunol . 1994;152:2660–2668
  7. Gamelli RL , Liu H , He LK , et al.   Augmentations of glucose uptake and glucose transporter-1 in macrophages following thermal injury and sepsis in mice . J Leukoc Biol . 1996;59:639–647
  8. Ahmed N , Kansara M , Berridge MV . Acute regulation of glucose transport in a monocyte-macrophage cell line (Glut-3 affinity for glucose is enhanced during the respiratory burst) . Biochem J . 1997;327:369–375
  9. Osman S , Danpure HJ . The use of 2-[18F]fluoro-2-deoxy-D-glucose as a potential in vitro agent for labeling human granulocytes for clinical studies by positron emission tomography . Int J Radiat Appl Instr . 1992;19:183–190
  10. Forstrom LA , Mullan BP , Hung JC , et al.   F-18-FDG labelling of human leukocytes . Nucl Med Commun . 2000;21:691–694
  11. Ishimori T , Saga T , Mamede M , et al.   Increased F-18-FDG uptake in a model of inflammation (Concanavalin A-mediated lymphocyte activation) . J Nucl Med . 2002;43:658–663
  12. Heelan BT , Osman S , Blyth A , et al.   Use of 2-[F-18]fluoro-2-deoxyglucose as a potential agent in the prediction of graft rejection by positron emission tomography . Transplantation . 1998;66:1101–1103
  13. Kubota R , Yamada S , Kubota K , et al.   Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo—High accumulation in macrophages and granulation tissues studied by microautoradiograph . J Nucl Med . 1992;33:1972–1980
  14. Sugawara Y , Gutowski TD , Fisher SJ , et al.   Uptake of positron emission tomography tracers in experimental bacterial infections (a comparative biodistribution study of radiolabeled FDG, thymidine, L-methionine, Ga-67-citrate, and I-125-HSA) . Eur J Nucl Med . 1999;26:333–341
  15. Brudin LH , Valind SO , Rhodes CG , et al.   Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography . Eur J Nucl Med . 1994;21:297–305
  16. Guhlmann A , Brecht-Krauss D , Suger G , et al.   Chronic osteomyelitis (Detection with FDG PET and correlation with histopathologic findings) . Radiology . 1998;206:749–754
  17. Skehan SJ , Issenman R , Mernagh J , et al.   F-18-fluorodeoxyglucose positron tomography in diagnosis of paediatric inflammatory bowel disease . Lancet . 1999;354:836–837
  18. Stumpe KDM , Dazzi H , Schaffner A , et al.   Infection imaging using whole-body FDG-PET . Eur J Nucl Med . 2000;27:822–832
  19. Tahara T , Ichiya Y , Kuwabara Y , et al.   High [18]-fluorodeoxyglucose uptake in abdominal abscesses (A PET study) . J Comput Assist Tomogr . 1989;5:829–831
  20. Okazumi S , Enomoto K , Ozaki M , et al.   [Evaluation of the effect of treatment in patients with liver tumors using 18F-fluorodeoxyglucose PET] . Kaku Igaku Jpn J Nucl Med . 1989;26:793–797
  21. Sasaki M , Ichiya Y , Kuwabara Y . Ringlike uptake of FDG in brain abscess (A PET study) . J Comp Assist Tomog . 1990;14:486–487
  22. Tsuyuguchi N , Sunada I , Ohata K , et al.   Evaluation of treatment effects in brain abscess with positron emission tomography (Comparison of fluorine-18- fluorodeoxyglucose and carbon-11-methionine) . Ann Nucl Med . 2003;17:47–51
  23. Yen RF , Chen ML , Liu FY , et al.   False-positive 2-[F-18]-fluoro-2-deoxy-D-glucose positron emission tomography studies for evaluation of focal pulmonary abnormalities . J Formos Med Assoc . 1998;97:642–645
  24. Kaya Z , Kotzerke J , Keller F . FDG PET diagnosis of septic kidney in a renal transplant patient . Transpl Int . 1999;12:156
  25. Bleeker-Rovers CP , de Sevaux RGL , van Hamersvelt HW , et al.   Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease . Am J Kidney Dis . 2003;41:E22
  26. Zimny M , Schroder W , Wolters S , et al.   18F-fluorodeoxyglucose PET in ovarian carcinoma (methodology and preliminary results) . Nuklearmedizin . 1997;36:228–233
  27. Schroder W , Zimny M , Rudlowski C , et al.   The role of F-18-fluoro-deoxyglucose positron emission tomography (F-18-FDG PET) in diagnosis of ovarian cancer . Int J Gynecol Cancer . 1999;9:117–122
  28. Kapucu LO , Meltzer CC , Townsend DW , et al.   Fluorine-18-fluorodeoxyglucose uptake in pneumonia . J Nucl Med . 1998;39:1267–1269
  29. Bakheet SM , Saleem M , Powe J , et al.   F-18 fluorodeoxyglucose chest uptake in lung inflammation and infection . Clin Nucl Med . 2000;25:273–278
  30. Tahon F , Berthezene Y , Hominal S , et al.   Exogenous lipoid pneumonia with unusual CT pattern and FDG positron emission tomography scan findings . Eur Radiol . 2002;12:S171–S173
  31. Jones HA , Clark RJ , Rhodes CG , et al.   Positron emission tomography of 18FDG uptake in localized pulmonary inflammation . Acta Radiol Suppl . 1991;376:148
  32. Jones HA , Sriskandan S , Peters AM , et al.   Dissociation of neutrophil emigration and metabolic activity in lobar pneumonia and bronchiectasis . Eur Resp J . 1997;10:795–803
  33. Zhuang H , Duarte PS , Pourdehand M , et al.   Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging . Clin Nucl Med . 2000;25:281–284
  34. Sugawara Y , Braun DK , Kison PV , et al.   Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography (Preliminary results) . Eur J Nucl Med . 1998;25:1238–1243
  35. Kalicke T , Schmitz A , Risse JH , et al.   Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases (results of histologically confirmed cases) . Eur J Nucl Med . 2000;27:524–528
  36. Guhlmann A , Brecht-Krauss D , Suger G , et al.   Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis . J Nucl Med . 1998;39:2145–2152
  37. Zhuang H , Duarte PS , Pourdehnad M , et al.   The promising role of F-18-FDG PET in detecting infected lower limb prosthesis implants . J Nucl Med . 2001;42:44–48
  38. Vanquickenborne B , Maes A , Nuyts J , et al.   The value of (18)FDG-PET for the detection of infected hip prosthesis . Eur J Nucl Med Mol Imaging . 2003;30:705–715
  39. Cremerius U , Mumme T , Reinartz P , et al.   Analysis of F-18-FDG uptake patterns in PET for diagnosis of septic and aseptic loosening after total hip arthroplasty . Nuklearmedizin-Nucl Med . 2003;42:234–239
  40. Bakheet SMB , Powe J , Ezzat A , et al.   F-18-FDG uptake in tuberculosis . Clin Nucl Med . 1998;23:739
  41. Hara T , Kosaka N , Suzuki T , et al.   Uptake rates of F-18-fluorodeoxyglucose and C-11-choline in lung cancer and pulmonary tuberculosis—A positron emission tomography study . Chest . 2003;124:893–901
  42. Reuter S , Schirrmeister H , Kratzer W , et al.   Pericystic metabolic activity in alveolar echinococcosis (Assessment and follow-up by positron emission tomography) . Clin Infect Dis . 1999;29:1157–1163
  43. Ozsahin H , von Planta M , Muller I , et al.   Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B . Blood . 1998;92:2719
  44. Franzius C , Biermann M , Hulskamp G , et al.   Therapy monitoring in aspergillosis using F-18FDG positron emission tomography . Clin Nucl Med . 2001;26:232–233
  45. Zhuang H , Pourdehnad M , Yamamoto AJ , et al.   Intense F-18 fluorodeoxyglucose uptake caused by Mycobacterium avium intracellulare infection . Clin Nucl Med . 2001;26:458
  46. O’Doherty MJ , Barrington SF , Campbell M , et al.   PET scanning and the human immunodeficiency virus-positive patient . J Nucl Med . 1997;38:1575–1583
  47. Bakheet SMB , Powe J , Kandil A , et al.   F-18FDG uptake in breast infection and inflammation . Clin Nucl Med . 2000;25:100–103
  48. Kresnik E , Mikosch P , Gallowitsch HJ , et al.   F-18 fluorodeoxyglucose positron emission tomography in the diagnosis of inflammatory bowel disease . Clin Nucl Med . 2001;26:867
  49. Hannah A , Scott AM , Akhurst T , et al.   Abnormal colonic accumulation of fluorine-18-FDG in pseudomembranous colitis . J Nucl Med . 1996;37:1683–1685
  50. Meyer MA . Diffusely increased colonic F-18 FDG uptake in acute enterocolitis . Clin Nucl Med . 1995;20:434–435
  51. Tomas MB , Tronco GG , Karayalcin G , et al.   FDG uptake in infectious mononucleosis . Clin Position Imaging . 2000;3:176
  52. Yasuda S , Shohtsu A , Ide M , et al.   Elevated F-18 FDG uptake in plasmacyte-rich chronic maxillary sinusitis . Clin Nucl Med . 1998;23:176–178
  53. Lewis PJ , Salama A . Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis . J Nucl Med . 1994;35:1647–1649
  54. Cook GJ , Fogelman I , Maisey MN . Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning (Potential for error in interpretation) . Semin Nucl Med . 1996;26:308–314
  55. Yamada Y , Uchida Y , Tatsumi K , et al.   Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis . J Nucl Med . 1998;39:1160–1166
  56. Yamagishi H , Shirai N , Takagi M , et al.   Identification of cardiac sarcoidosis with N-13-NH3/F-18-FDG PET . J Nucl Med . 2003;44:1030–1036
  57. Yasuda S , Raja S , Hubner KF . Application of whole-body positron emission tomography in the imaging of esophageal cancer (report of a case) . Surg Today . 1995;25:261–264
  58. Taylor IK , Hill AA , Hayes M , et al.   Imaging allergen-invoked airway inflammation in atopic asthma with [18F]-fluorodeoxyglucose and positron emission tomography . Lancet . 1996;347:937–940
  59. Alavi A , Gupta N , Alberini JL , et al.   Positron emission tomography imaging in nonmalignant thoracic disorders . Semin Nucl Med . 2002;32:293–321
  60. Gysen M , Stroobants S , Mortelmans L . Proliferative myositis (A case of a pseudomalignant process) . Clin Nucl Med . 1998;23:836–838
  61. Yasuda S , Shohtsu A , Ide M , et al.   Diffuse F-18 FDG uptake in chronic thyroiditis . Clin Nucl Med . 1997;22:341
  62. Imran MB , Kubota K , Yoshioka S , et al.   Sclerosing mediastinitis (Findings on fluorine-18 fluorodeoxyglucose positron emission tomography) . Clin Nucl Med . 1999;24:305–308
  63. Nunez RF , Yeung HW , Macapinlac H . Increased F-18 FDG uptake in the stomach . Clin Nucl Med . 1999;24:281–282
  64. Becker W , Goldenberg DM , Wolf F . The use of monoclonal-antibodies and antibody fragments in the imaging of infectious lesions . Semin Nucl Med . 1994;24:142–153
  65. de Kleijn EM , Oyen WJ , Corstens FH , et al.   Utility of indium-111-labeled polyclonal immunoglobulin G scintigraphy in fever of unknown origin. The Netherlands FUO Imaging Group . J Nucl Med . 1997;38:484–489
  66. Fischman A , Babich J , Strauss H . A ticket to ride (Peptide radiopharmaceuticals) . J Nucl Med . 1993;4:2253–2263
  67. van der Laken CJ , Boerman OC , Oyen WJ , et al.   Scintigraphic detection of infection and inflammation (New developments with special emphasis on receptor interaction) . Eur J Nucl Med . 1998;25:535–546
  68. Boerman OC , Rennen H , Oyen WJG , et al.   Radiopharmaceuticals to image infection and inflammation . Semin Nucl Med . 2001;31:286–295
  69. Laverman P , Oyen WJG , Storm G , et al.   Improved imaging of infection by avidin induced clearance of Tc-99m-biotin-PEG-liposomes . J Nucl Med . 1998;39:267P
  70. De Winter F , Gemmel F , Van de Wiele C . Prospective comparison of Tc-99m ciprofloxacin (infection) SPECT and F-18 FDG PET for the diagnosis of chronic orthopaedic infections in the central skeleton (COICS) . J Nucl Med . 2002;43:477; [abstr]
  71. De Winter F , Vogelaers D , Gemmel F , et al.   Promising role of 18-F-fluoro-D-deoxyglucose positron emission tomography in clinical infectious diseases . Eur J Clin Microbiol Infect Dis . 2002;21:247–257
  72. Zhuang H , Pourdehnad M , Lambright ES , et al.   Dual time point F-18-FDG PET imaging for differentiating malignant from inflammatory processes . J Nucl Med . 2001;42:1412–1417
  73. Matthies A , Hickeson M , Cuchiara A , et al.   Dual time point F-18-FDG PET for the evaluation of pulmonary nodules . J Nucl Med . 2002;43:871–875
  74. Conrad GR , Sinha P . Narrow time-window dual-point F-18-FDG PET for the diagnosis of thoracic malignancy . Nucl Med Commun . 2003;24:1129–1137
  75. Palestro CJ , Torres MA . Radionuclide imaging in orthopedic infections . Semin Nucl Med . 1997;27:334–345
  76. Perry M . Erythrocyte sedimentation rate and C reactive protein in the assessment of suspected bone infection—Are they reliable indices? . J R Coll Surg Edinb . 1996;41:116–118
  77. Sanzen L , Sundberg M . Periprosthetic low-grade hip infections—Erythrocyte sedimentation rate and C-reactive protein in 23 cases . Acta Orthop Scand . 1997;68:461–465
  78. Fluckiger U , Zimmerli W . Diagnosis and follow-up management of postoperative bacterial osteomyelitis . Orthopade . 2004;33:416–423
  79. Erdman WA , Tamburro F , Jayson HT , et al.   Osteomyelitis—Characteristics and pitfalls of diagnosis with MR imaging . Radiology . 1991;180:533–539
  80. Crim JR , Seeger LL . Imaging evaluation of osteomyelitis . Crit Rev Diagn Imaging . 1994;35:201–256
  81. Ledermann HP , Kaim A , Bongartz G , et al.   Pitfalls and limitations of magnetic resonance imaging in chronic posttraumatic osteomyelitis . Eur Radiol . 2000;10:1815–1823
  82. Datz FL . Indium-111 labeled leukocytes for the detection of infection (Current status) . Semin Nucl Med . 1994;24:92–109
  83. Seabold JE , Nepola JV . Imaging techniques for evaluation of postoperative orthopedic infections . Qtr J Nucl Med . 1999;43:21–28
  84. Kaim A , Maurer T , Ochsner P , et al.   Chronic complicated osteomyelitis of the appendicular skeleton (diagnosis with technetium-99m labelled monoclonal antigranulocyte antibody-immunoscintigraphy) . Eur J Nucl Med . 1997;24:732–738
  85. Kaim A , Ledermann HP , Bongartz G , et al.   Chronic post-traumatic osteomyelitis of the lower extremity (comparison of magnetic resonance imaging and combined bone scintigraphy/immunoscintigraphy with radiolabelled monoclonal antigranulocyte antibodies) . Skeletal Radiol . 2000;29:378–386
  86. Jacobson AF , Gilles CP , Cerqueira MD . Photopenic defects in marrow-containing skeleton on in-111 leukocyte scintigraphy—Prevalence at sites suspected of osteomyelitis and as an incidental finding . Eur J Nucl Med . 1992;19:858–864
  87. De Winter F , Van de Wiele C , Vogelaers D , et al.   Fluorine-18 fluorodeoxyglucose-positron emission tomography (A highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections) . J Bone Joint Surg Am . 2001;83A:651–660
  88. Meller J , Koster G , Liersch T , et al.   Chronic bacterial osteomyelitis (prospective comparison of F- 18-FDG imaging with a dual-head coincidence camera and In-111-labelled autologous leucocyte scintigraphy) . Eur J Nucl Med . 2002;29:53–60
  89. Robiller FC , Stumpe KDM , Kossmann T , et al.   Chronic osteomyelitis of the femur (Value of PET imaging) . Eur Radiol . 2000;10:855–858
  90. Schmitz A , Risse JH , Textor J , et al.   FDG-PET findings of vertebral compression fractures in osteoporosis (Preliminary results) . Osteoporosis Int . 2002;13:755–761
  91. Zhuang H , Sam JW , Chacko TK , et al.   Rapid normalization of osseous FDG uptake following traumatic or surgical fractures . Eur J Nucl Med Mol Imaging . 2003;30:1096–1103
  92. Chacho TK , Zhuang H , Nakhoda KZ , et al.   Application of fluorodeoxyglucose positron emission tomography in the diagnosis of infection . Nucl Med Commun . 2003;24:615–624
  93. Palestro CJ , Kim CK , Swyer AJ , et al.   Total-hip arthroplasty (periprosthetic indium-111 labeled leukocyte activity and complementary technetium-99m-sulfur colloid imaging in suspected infection) . J Nucl Med . 1990;31:1950–1954
  94. Scher DM , Pak K , Lonner JH , et al.   The predictive value of indium-111 leukocyte scans in the diagnosis of infected total hip, knee, or resection arthroplasties . J Arthroplast . 2000;15:295–300
  95. Schmitz A , Risse HJ , Kalicke T , et al.   FDG-PET for diagnosis and follow-up of inflammatory processes (First results from an orthopedic view) . Z Orthop Grenzg . 2000;138:407–412
  96. Love C , Pugliese PV , Afriyie MO , et al.   Utility of F18 FDG imaging for diagnosing the infected joint replacement . Clin Postron Imaging . 2000;3:159
  97. Zhuang H , Chacko TK , Hickeson M , et al.   Persistent non-specific FDG uptake on PET imaging following hip arthroplasty . Eur J Nucl Med Mol Imaging . 2002;29:1328–1333
  98. Chacko TK , Zhuang H , Stevenson K , et al.   The importance of the location of fluorodeoxyglucose uptake in periprosthetic infection in painful hip prostheses . Nucl Med Commun . 2002;23:851–855
  99. Manthey N , Reinhard P , Moog F , et al.   The use of F-18 fluorodeoxyglucose positron emission tomography to differentiate between synovitis, loosening and infection of hip and knee prostheses . Nucl Med Commun . 2002;23:645–653
  100. De Winter F , Van de Wiele C , De Clercq D , et al.   Aseptic loosening of a knee prosthesis as imaged on FDG positron emission tomography . Clin Nucl Med . 2000;25:923
  101. Stumpe K , Nötzli H , Zanetti M , et al.   FDG PET for Differentiation of infection and aseptic loosening in total hip replacements (Comparison with conventional radiography and three-phase bone scintigraphy) . Radiology . 2004;231:333–341
  102. Knockaert DC , Mortelmans LA , Deroo MC , et al.   Clinical-value of Ga-67 scintigraphy in Evaluation of Fever of Unknown Origin . Clin Infect Dis . 1994;18:601–605
  103. Syrjala MT , Valtonen V , Liewendahl K , et al.   Diagnostic-significance of in-111 granulocyte scintigraphy in febrile patients . J Nucl Med . 1987;28:155–160
  104. Peters AM . Nuclear medicine imaging in fever of unknown origin . Qtr J Nucl Med . 1999;43:61
  105. Blockmans D , Knockaert D , Maes A , et al.   Clinical value of [F-18]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin . Clin Infect Dis . 2001;32:191–196
  106. Meller J , Altenvoerde G , Munzel U , et al.   Fever of unknown origin (Prospective comparison of [F-18]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET) . Eur J Nucl Med . 2000;27:1617–1625
  107. Meller J , Sahlmann CO , Lehmann K , et al.   F-18-FDG-hybrid-camera-PET in patients with postoperative fever . Nuklearmedizin-Nucl Med . 2002;41:22–29
  108. Bleeker-Rovers CP , de Kleijn E , Corstens FHM , et al.   Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation . Eur J Nucl Med Mol Imaging . 2004;31:29–37
  109. Derdelinckx I , Maes A , Bogaert J , et al.   Positron emission tomography scan in the diagnosis and follow-up of aortitis of the thoracic aorta . Acta Cardiol . 2000;55:193–195
  110. Scharko AM , Perlman SB , Hinds PW , et al.   Whole body positron emission tomography imaging of simian immunodeficiency virus-infected rhesus macaques . Proc Natl Acad Sci USA . 1996;93:6425–6430
  111. Scharko AM , Perlman SB , Pyzalski RW , et al.   Whole-body positron emission tomography in patients with HIV-1 infection . Lancet . 2003;362:959–961
  112. Levy R , Mills C , Posin J , et al.   The efficacy and clinical impact of brain imaging in neurologically symptomatic AIDS patients (A prospective CT/MRI study) . J Acquir Immune Defic Syndr . 1990;3:461–471
  113. Porter S , Sande M . Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome . N Engl J Med . 1992;327:1643–1648
  114. Biggar R , Rabkin C . The epidemiology of AIDS-related neoplasms . Hematol Oncol Clin North Am . 1996;10:997–1010
  115. Naddaf SY , Akisik MF , Aziz M , et al.   Comparison between 201Tl-chloride and 99Tc(m)-sestamibi SPET brain imaging for differentiating intracranial lymphoma from non-malignant lesions in AIDS patients . Nucl Med Commun . 1998;19:47–53
  116. Antinori A , Ammassari A , Luzzati R , et al.   Role of brain biopsy in the management of focal brain lesions in HIV-infected patients. Gruppo Italiano Cooperativo AIDS & Tumori . Neurology . 2000;54:993–997
  117. Hoffman JM , WH A , Schifter T . FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS . J Nucl Med . 1993;34:567–575
  118. Heald AE , Hoffman JM , Bartlett JA , et al.   Differentiation of central nervous system lesions in AIDS patients using positron emission tomography (PET) . Int J STD AIDS . 1996;7:337
  119. Yasuda S , Shohtsu A , Ide M , et al.   High fluorine-18 labeled deoxyglucose uptake in sarcoidosis . Clin Nucl Med . 1996;21:983–984
  120. Alavi A , Buchpiguel CA , Loessner A . Is there a role for FDG PET imaging in the management of patients with sarcoidosis? . J Nucl Med . 1994;35:1650–1652 [editorial; comment]
  121. Ross R . The pathogenesis of atherosclerosis (A perspective for the 1990s) . Nature . 1990;362:801–809
  122. Strong J , Malcom G , McMahan C , et al.   Prevalence and extent of atherosclerosis in adolescents and young adults (Implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study) . JAMA . 1999;281:727–735
  123. Stary H , Chandler A , Dinsmore R , et al.   A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association . Circulation . 1995;92:1355–1374
  124. Libby P , Ridker P , Maseri A . Inflammation and atherosclerosis . Circulation . 2002;105:1135–1143
  125. van der Wal A , Becker A , van der Loos C , et al.   Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology . Circulation . 1994;89:36–44
  126. Ross R . Atherosclerosis—an inflammatory disease . N Engl J Med . 1999;340:115–126
  127. Capron L . Chlamydia in coronary plaques—hidden culprit or harmless hobo? . Nat Med . 1996;2:856–857
  128. Muhlestein J , Hammond E , Carlquist J , et al.   Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease . J Am Coll Cardiol . 1996;27:1555–1561
  129. Muhlestein J , Anderson J , Hammond E , et al.   Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model . Circulation . 1998;97:633–636
  130. Blum A , Giladi M , Weinberg M , et al.   High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis . Am J Cardiol . 1998;81:866–868
  131. Sorlie P , Nieto F , Adam E , et al.   A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease (The atherosclerosis risk in communities (ARIC) study) . Arch Intern Med . 2000;160:2027–2032
  132. Mayr M , Kiechl S , Mendall M , et al.   Increased risk of atherosclerosis is confined to CagA-positive Helicobacter pylori strains (Prospective results from the Bruneck study) . Stroke . 2003;34:610–615
  133. Vallabhajosula S , Machac J , Knesaurek KK , et al.   Imaging atherosclerotic macrophage density by positron emission tomography using F-18-fluorodeoxyglucose (FDG) (abstr) . J Nucl Med . 1996;37:144
  134. Yun MJ , Jang S , Cucchiara A , et al.   F-18 FDG uptake in the large arteries (A correlation study with the atherogenic risk factors) . Semin Nucl Med . 2002;32:70–76
  135. Lederman RJ , Raylman RR , Fisher SJ , et al.   Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG) . Nucl Med Commun . 2001;22:747–753
  136. Tatsumi M , Cohade C , Nakamoto Y , et al.   Fluorodeoxyglucose uptake in the aortic wall at PET/CT (Possible finding for active atherosclerosis) . Radiology . 2003;229:831–837
  137. Hunder G , Arend W , Bloch D , et al.   The American College of Rheumatology 1990 criteria for the classification of vasculitis . Introduction. Arthritis Rheum . 1990;33:1065–1067
  138. Theron J , Tyler JL . Takayasus-arteritis of the aortic-arch - Endovascular treatment and correlation with positron emission tomography . Am J Neuroradiol . 1987;8:621–626
  139. Blockmans D , Maes A , Stroobants S , et al.   New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography . Rheumatology . 1999;38:444–447
  140. Hara M , Goodman PC , Leder RA . FDG-PET finding in early-phase Takayasu arteritis . J Comput Assist Tomogr . 1999;23:16–18
  141. Meller J , Grabbe E , Becker W , et al.   Value of F-18FDG hybrid camera PET and MRI in early takayasu aortitis . Eur Radiol . 2003;13:400–405
  142. Meller J , Strutz F , Siefker J , et al.   Early diagnosis and follow-up of aortitis with F-18 FDG PET and MRI . Eur J Nucl Med Mol Imaging . 2003;30:730–736
  143. Webb M , Chambers A , Al-Nahhas A , et al.   The role of F-18-FDG PET in characterising disease activity in Takayasu arteritis . Eur J Nucl Med Mol Imaging . 2004;31:627–634
  144. Balan K , Voutnis D , Groves A . Discordant uptake of F-18FDG and In-111WBC in systemic vasculitis . Clin Nucl Med . 2003;28:485–486
  145. Brodmann M , Lipp RW , Passath A , et al.   The role of 2-F-18-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries . Rheumatology . 2004;43:241–242
  146. Bar-Shalom R , Valdivia AY , Blaufox MD . PET imaging in oncology . Semin Nucl Med . 2000;30:150–185
  147. Moloney G , Walker I . Talking about transplants (social representations and the dialectical, dilemmatic nature of organ donation and transplantation) . Br J Soc Psychol . 2002;41:299–320
  148. Yasuda S , Kubota M , Tajima T , et al.   A small breast cancer detected by PET . Jpn J Clin Oncol . 1999;29:387
  149. Hoff SJ , Stewart JR , Frist WH , et al.   Noninvasive detection of heart-transplant rejection with positron emission scintigraphy . Ann Thorac Surg . 1992;53:572–577
  150. Rechavia E , deSilva R , Kushwaha SS , et al.   Enhanced myocardial F-18-2-fluoro-2-deoxyglucose uptake after orthotopic heart transplantation assessed by positron emission tomography . J Am Coll Cardiol . 1997;30:533–538
  151. Jones H , Donovan T , Goddard M , et al.   Use of 18FDG-PET to discriminate between infection and rejection in lung transplant recipients . Transplantation . 2004;77:1462–1464
  152. Marom EM , McAdams HP , Butnor KJ , et al.   Positron emission tomography with fluoro-2-deoxy-d-glucose (FDG-PET) in the staging of post transplant lymphoproliferative disorder in lung transplant recipients . J Thorac Imaging . 2004;19:74–78
  153. Smith GT , Wilson TS , Hunter K , et al.   Assessment of skeletal-muscle viability By PET . J Nucl Med . 1995;36:1408–1414
  154. Aigner RM , Schultes G , Wolf G , et al.   F-18-FDG PET (Early postoperative period of oro-maxillo-facial flaps) . Nuklearmedizin-Nucl Med . 2003;42:210–214
  155. Kostakoglu L , Wong J , Barrington S , et al.   Speech-related visualization of laryngeal muscles with fluorine-18-FDG . J Nucl Med . 1996;37:1771–1773
  156. Hany TF , Gharehpapagh E , Kamel EM , et al.   Brown adipose tissue (a factor to consider in symmetrical tracer uptake in the neck and upper chest region) . Eur J Nucl Med Mol Imaging . 2002;29:1393–1398
  157. Yeung HWD , Grewal RK , Gonen M , et al.   Patterns of F-18-FDG uptake in adipose tissue and muscle (A potential source of false-positives for PET) . J Nucl Med . 2003;44:1789–1796
  158. Barrington S , Maisey M . Skeletal muscle uptake of fluorine-18-FDG (Effect of oral diazepam) . J Nucl Med . 1996;37:1127–1129
  159. Tashiro M , Fujimoto T , Itoh M , et al.   F-18-FDG PET imaging of muscle activity in runners . J Nucl Med . 1999;40:70–76
  160. Oi N , Iwaya T , Itoh M , et al.   FDG-PET imaging of lower extremity muscular activity during level walking . J Orthop Sci . 2003;8:55–61
  161. Pappas G , Olcott E , Drace J . Imaging of skeletal muscle function using (18)FDG PET (Force production, activation, and metabolism) . J Appl Physiol . 2001;90:329–337
  162. Murrell G , Walton J . Diagnosis of rotator cuff tears . Lancet . 2001;357:769–770
  163. Shinozaki T , Takagishi K , Ichikawa A , et al.   Use of 2- F-18 -fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) imaging for the evaluation of muscle metabolic activity in ruptured rotator cuffs (Identification of shoulder muscles by fusion imaging studies involving both FDG PET and magnetic resonance imaging) . J Shoulder Elbow Surg . 2003;12:544–549
  164. Bicik I , Bauerfeind P , Breitbach T , et al.   Inflammatory bowel disease activity measured by positron-emission tomography . Lancet . 1997;350:262
  165. Neurath MF , Vehling M , Schunk K , et al.   FDG-PET (A novel non-invasive method to detect affected bowel segments in Crohn’s disease?) . Gastroenterology . 2000;118:1749
  166. Neurath MF , Vehling D , Schunk K , et al.   Noninvasive assessment of Crohn’s disease activity (A comparison of F-18-fluorodeoxlyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies) . Am J Gastroenterol . 2002;97:1978–1985
  167. Shreve PD , Anzai Y , Wahl RL . Pitfalls in oncologic diagnosis with FDG PET imaging (physiologic and benign variants) . RadioGraphics . 1999;19:61–77
  168. Miraldi F , Vesselle H , Faulhaber PF , et al.   Elimination of artifactual accumulation of FDG in PET imaging of colorectal cancer . Clin Nucl Med . 1998;23:3–7
  169. Pio B , Byrne F , Aranda R , et al.   Noninvasive quantification of bowel inflammation through positron emission tomography imaging of 2-deoxy-2-[18F]fluoro-D-glucose-labeled white blood cells . Mol Imaging Biol . 2003;5:271–277
  170. Wagner G . Asbestosis and silicosis . Lancet . 1997;349:1311–1315
  171. Lapp N , Castranova V . How silicosis and coal workers’ pneumoconiosis develop—a cellular assessment . Occup Med . 1993;8:35–56
  172. Piguet P , Vesin C . Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice . Eur Respir J . 1994;7:515–518
  173. Strauss LG . Fluorine-18 deoxyglucose and false-positive results (A major problem in the diagnostics of oncological patients) . Eur J Nucl Med . 1996;23:1409–1415
  174. Konishi J , Yamazaki K , Tsukamoto E , et al.   Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer (analysis of false-positive FDG-PET findings) . Respiration . 2003;70:500–506
  175. Cook GJR , Maisey MN , Fogelman I . Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine . Eur J Nucl Med . 1999;26:1363–1378
  176. Wallace WE , Gupta NC , Hubbs AF , et al.   Cis-4- F-18 fluoro-L-proline PET imaging of pulmonary fibrosis in a rabbit model . J Nucl Med . 2002;43:413–420
  177. Moskowitz H , Platt R , Schachar R , et al.   Roentgen visualization of minute pleural effusion. An experimental study to determine the minimum amount of pleural fluid visible on a radiograph . Radiology . 1973;109:33–35
  178. Falaschi F , Battolla L , Mascalchi M , et al.   Usefulness of MR signal intensity in distinguishing benign from malignant pleural disease . AJR Am J Roentgenol . 1996;166:963–968
  179. Boutin C , Loddenkemper R , Astoul P . Diagnostic and therapeutic thoracoscopy (Techniques and indications in pulmonary medicine) . Tuber Lung Dis . 1993;74:225–239
  180. Boutin C , Viallat J , Cargnino P , et al.   Thoracoscopy in malignant pleural effusions . Am Rev Respir Dis . 1981;124:588–592
  181. Benard F , Sterman D , Smith R , et al.   Metabolic imaging of malignant mesothelioma with Fluorine-18-deoxyglucose positron emission tomography . Chest . 1998;114:713–722
  182. Jadvar H , Fischman A . Evaluation of rare tumors with [F-18]fluorodeoxyglucose positron emission tomography . Clin Positron Imaging . 1999;2:153–158
  183. Gerbaudo VH , Sugarbaker DJ , Britz-Cunningham S , et al.   Assessment of malignant pleural mesothelioma with F-18-FDG dual-head gamma-camera coincidence imaging (Comparison with histopathology) . J Nucl Med . 2002;43:1144–1149
  184. Balogova S , Grahek D , Kerrou K , et al.   [18F]-FDG imaging in apparently isolated pleural lesions . Rev Pneumol Clin . 2003;59:275–288
  185. Schneider DB , Clary-Macy C , Challa S , et al.   Positron emission tomography with F18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma . J Thorac Cardiovasc Surg . 2000;120:128–133
  186. Zubeldia J , Abou-Zied M , Nabi H . Evaluation of patients with known mesothelioma with 18F-fluorodeoxyglucose and PET. Comparison with computed tomography . Clin Positron Imaging . 2000;3:165
  187. Belhocine TZ , Daenen F , Duysinx B , et al.   Typical appearance of mesothelioma on an F-18FDG positron emission tomograph . Clin Nucl Med . 2000;25:636
  188. Benard F , Sterman D , Smith R , et al.   Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography . Chest . 1998;114:713–722
  189. Benard F , Alavi A , Sterman D , et al.   The prognostic value of FDG-PET imaging in malignant pleural mesothelioma . J Nucl Med . 1998;39:81P
  190. Naruke T , Goya T , Tsuchiya R , et al.   Prognosis and survival in resected lung carcinoma based on the new international staging system . J Thorac Cardiovasc Surg . 1988;96:440–447
  191. Erasmus JJ , McAdams HP , Rossi SE , et al.   FDG PET of pleural effusions in patients with non-small cell lung cancer . Am J Roentgenol . 2000;175:245–249
  192. Gupta NC , Rogers JS , Graeber GM , et al.   Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion . Chest . 2002;122:1918–1924
  193. Bury T , Paulus P , Dowlati A , et al.   Evaluation of pleural diseases with FDG-PET imaging (Preliminary report) . Thorax . 1997;52:187–189
  194. Buchmann I , Guhlmann C , Elsner K , et al.   [F-18-FDG PET for primary diagnosis differential diagnosis of pleural processes] . Nuklearmedizin . 1999;38:319–322
  195. Carretta A , Landoni C , Melloni G , et al.   18-FDG positron emission tomography in the evaluation of malignant pleural diseases—A pilot study . Eur J Cardio-Thorac Surg . 2000;17:377–382
  196. Patel PM , Alibazoglu H , Ali A , et al.   Normal thymic uptake of FDG on PET imaging . Clin Nucl Med . 1996;21:772–775
  197. Nakahara T , Fujii H , Ide M , et al.   FDG uptake in the morphologically normal thymus (Comparison of FDG positron emission tomography and CT) . Br J Radiol . 2001;74:821–824
  198. Brink I , Reinhardt M , Hoegerle S , et al.   Increased metabolic activity in the thymus gland studied with 18F-FDG PET (Age dependency and frequency after chemotherapy) . J Nucl Med . 2001;42:591–595
  199. Alibazoglu H , Alibazoglu B , Hollinger EF , et al.   Normal thymic uptake of 2-deoxy-2[F-18]fluoro-D-glucose . Clin Nucl Med . 1999;24:597
  200. Pagliai F , Rigacci L , Briganti V , et al.   PET scan evaluation of thymic mass after autologous peripheral blood stem-cell transplantation in an adult with non-Hodgkin’s lymphoma . Leuk Lymphoma . 2003;44:2015–2018
  201. Hardy G , Worrell S , Hayes P , et al.   Evidence of thymic reconstitution after highly active antiretroviral therapy in HIV-1 infection . HIV Med . 2004;5:67–73
  202. Uematsu H , Sadato N , Ohtsubo T , et al.   Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors . J Nucl Med . 1998;39:453–459
  203. Drieskens O , Blockmans D , Van den Bruel A , et al.   Riedel’s thyroiditis and retroperitoneal fibrosis in multifocal fibrosclerosis positron emission tomographic findings . Clin Nucl Med . 2002;27:413–415
  204. Schmid DT , Kneifel S , Stoeckli SJ , et al.   Increased 18F-FDG uptake mimicking thyroid cancer in a patient with Hashimoto’s thyroiditis . Eur Radiol . 2003;13:2119–2121
  205. Santiago J , Jana S , El-Zeftawy H , et al.   Increased F-18 fluorodeoxyglucose thyroidal uptake in Graves’ disease . Clin Nucl Med . 1999;24:714–715
  206. Cohen MS , Arslan N , Dehdashti F , et al.   Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography . Surgery . 2001;130:941–946
  207. Deichen JT , Schmidt C , Prante O , et al.   Influence of TSH on uptake of F-18 fluorodeoxyglucose in human thyroid cells in vitro . Eur J Nucl Med Mol Imaging . 2004;31:507–512
  208. Moog F , Linke R , Manthey N , et al.   Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinoma . J Nucl Med . 2000;41:1989–1995
  209. Petrich T , Borner AR , Weckesser E , et al.   Follow-up of thyroid cancer patients using rhTSH— Preliminary results . Nuklearmedizin-Nucl Med . 2001;40:7–14
  210. Chin BB , Patel P , Cohade C , et al.   Recombinant human thyrotropin stimulation of fluoro-D-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma . J Clin Endocrinol Metab . 2004;89:91–95
  211. von Schulthess GK , Meier N , Stumpe KDM . Joint accumulations of FDG in whole body PET scans . Nuklearmedizin-Nucl Med . 2001;40:193–197
  212. Palmer WE , Schoenberg OI , Fischman AJ , et al.   FDG Metabolism in the wrist during treatment of inflammatory arthritis—Quantification with pet and correlation with clinical-response . J Nucl Med . 1994;35:35
  213. Roivainen A , Parkkola R , Yli-Kerttula T , et al.   Use of positron emission tomography with methyl-C-11-choline and 2-F-18-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium . Arthritis Rheum . 2003;48:3077–3084
  214. Chang KJ , Zhuang H , Alavi A . Detection of chronic recurrent lower extremity deep venous thrombosis on fluorine-18 fluorodeoxyglucose positron emission tomography . Clin Nucl Med . 2000;25:838–839
  215. Lin EC , Quaife RA . FDG uptake in chronic superior vena cava thrombus on positron emission tomographic imaging . Clin Nucl Med . 2001;26:241–242
  216. Raman S , Nunez R , Wong CO , et al.   F-18FDG positron emission tomographic image of an aortic aneurysmal thrombus . Clin Nucl Med . 2002;27:213–214
  217. Bhargava P , Kumar R , Zhuang H , et al.   Catheter-related focal FDG activity on whole body PET imaging . Clin Nucl Med . 2004;29:238–242

PII: S0001-2998(04)00044-3

doi: 10.1053/j.semnuclmed.2004.06.006

Seminars in Nuclear Medicine
Volume 34, Issue 4 , Pages 313-329 , October 2004

Article Tools

* Image Usage & Resolution